A Hemorrhagic Clival Chordoma with a Long Progression-Free Survival

被引:6
|
作者
Vilela, Marcelo D. [1 ,2 ]
Pedrosa, Hugo A. S. [1 ]
Dias Filho, Marco Antonio [3 ]
机构
[1] Mater Dei Hosp, Dept Neurosurg, Belo Horizonte, MG, Brazil
[2] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA
[3] Lab Anat & Patol Diagnost, Belo Horizonte, MG, Brazil
关键词
Chordoma; Ecchordosis physaliphora; Hemorrhage; ENDOTHELIAL GROWTH-FACTOR; ECCHORDOSIS-PHYSALIPHORA; INTRATUMORAL HEMORRHAGE; EXPRESSION; VEGF;
D O I
10.1016/j.wneu.2017.06.169
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Chordomas and ecchordosis physaliphora may on rare occasions present with intracranial hemorrhage. Their distinction usually relies on the results of the Ki-67 proliferative index, with a result lower than 1% favoring ecchordosis physaliphora. Intracranial hemorrhagic chordomas have been linked to unfavorable prognosis, due to acute neurologic deterioration and death, or progression after treatment. To the best of our knowledge, this is the first report of a patient with an intracranial hemorrhagic chordoma who had a long progression-free survival. CASE DESCRIPTION: A 67-year-old woman presented with a large hemorrhagic clival tumor that was resected through an endonasal endoscopic approach. Physallipharous cells interspersed in a myxoid matrix, positivity for S-100, cytokeratin, and epithelial membrane antigen were found, along with an extremely low Ki-67 index. Imaging findings of bone erosion, a large size, and enhancement favored the diagnosis of chordoma. The patient received adjuvant stereotactic radiotherapy and has remained disease free after 4 years. CONCLUSIONS: Although hemorrhagic intracranial chordomas have been linked to unfavorable outcomes, our case demonstrates that they may have a low proliferative index, and a long progression-free survival may be seen.
引用
收藏
页码:1042.e1 / 1042.e4
页数:4
相关论文
共 50 条
  • [1] A nomogram to predict the progression-free survival of clival chordoma
    Zhai, Yixuan
    Bai, Jiwei
    Li, Mingxuan
    Wang, Shuai
    Li, Chuzhong
    Wei, Xinting
    Zhang, Yazhuo
    JOURNAL OF NEUROSURGERY, 2021, 134 (01) : 144 - 152
  • [2] Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery
    Passeri, Thibault
    di Russo, Paolo
    Champagne, Pierre-Olivier
    Bernat, Anne-Laure
    Cartailler, Jerome
    Guichard, Jean Pierre
    Mammar, Hamid
    Giammattei, Lorenzo
    Adle-Biassette, Homa
    George, Bernard
    Mandonnet, Emmanuel
    Froelich, Sebastien
    NEUROSURGERY, 2021, 89 (02) : 291 - 299
  • [3] Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival
    S. H. Bakker
    W. C. H. Jacobs
    W. Pondaag
    H. Gelderblom
    R. A. Nout
    P. D. S. Dijkstra
    W. C. Peul
    C. L. A. Vleggeert-Lankamp
    European Spine Journal, 2018, 27 : 3043 - 3058
  • [4] Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival
    Bakker, S. H.
    Jacobs, W. C. H.
    Pondaag, W.
    Gelderblom, H.
    Nout, R. A.
    Dijkstra, P. D. S.
    Peul, W. C.
    Vleggeert-Lankamp, C. L. A.
    EUROPEAN SPINE JOURNAL, 2018, 27 (12) : 3043 - 3058
  • [5] Development and validation of a preoperative MRI-based radiomics nomogram to predict progression-free survival in patients with clival chordomas
    Zhai, Yixuan
    Bai, Jiwei
    Xue, Yake
    Li, Mingxuan
    Mao, Wenbin
    Zhang, Xuezhi
    Zhang, Yazhuo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence
    Ito, Eiji
    Saito, Kiyoshi
    Okada, Takeshi
    Nagatani, Tetsuya
    Nagasaka, Tetsuro
    ACTA NEUROCHIRURGICA, 2010, 152 (01) : 57 - 67
  • [7] Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors
    Kanamori, Masayuki
    Kumabe, Toshihiro
    Sonoda, Yukihiko
    Nishino, Yoshikazu
    Watanabe, Mika
    Tominaga, Teiji
    JOURNAL OF NEURO-ONCOLOGY, 2009, 93 (02) : 219 - 228
  • [8] T-antigen as a biomarker of progression-free survival in patients with glioblastoma
    Guan, Liao
    Wang, Wenwen
    Ji, Xuefei
    Cheng, Hongwei
    Du, Weidong
    Ye, Lei
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (07): : 1765 - 1774
  • [9] Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
    Hogdall, Estrid
    Fung, Eric T.
    Christensen, Ib Jarle
    Yip, Christine
    Nedergaard, Lotte
    Engelholm, Svend Aage
    Risum, Signe
    Petri, Anette Lykke
    Lundvall, Lene
    Lomas, Lee
    Hogdall, Claus
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (12) : 940 - 952
  • [10] Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation
    Peng, Jianfeng
    Zhao, Xianguang
    Zhao, Kaikai
    Meng, Xiangjiao
    FRONTIERS IN ONCOLOGY, 2021, 11